Three sufferers (2
Three sufferers (2.8%) experienced a significant adverse event throughout their involvement in the vaccine substudy, but these occasions weren’t considered linked to vaccine administration. Discussion Within this substudy of a continuing stage 3 LTE in sufferers with RA, we examined the result of baricitinib on vaccine LY2857785 responses to PCV-13 and TTV. pneumococcal conjugate vaccine … [Read more…]